Solid Biosciences Inc. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (8 lists). Names and jurisdictions are as filed.
- 2026-03-19: Subsidiary AavantiBio, Inc.; Jurisdiction Delaware.
- 2026-03-19: Subsidiary Solid Biosciences Securities Corporation; Jurisdiction Massachusetts.
- 2025-03-06: Subsidiary AavantiBio, Inc.; Jurisdiction Delaware.
- 2025-03-06: Subsidiary Solid Biosciences Securities Corporation; Jurisdiction Massachusetts.
| Annual report filed | Subsidiary | Jurisdiction |
|---|
| 2026-03-19 | AavantiBio, Inc. | Delaware |
|---|
| 2026-03-19 | Solid Biosciences Securities Corporation | Massachusetts |
|---|
| 2025-03-06 | AavantiBio, Inc. | Delaware |
|---|
| 2025-03-06 | Solid Biosciences Securities Corporation | Massachusetts |
|---|
| 2024-03-13 | AavantiBio, Inc. | Delaware |
|---|
| 2024-03-13 | Solid Biosciences Securities Corporation | Massachusetts |
|---|
| 2023-03-23 | AavantiBio, Inc. | Delaware |
|---|
| 2023-03-23 | Solid Biosciences Securities Corporation | Massachusetts |
|---|
| 2022-03-14 | Solid Biosciences UK Limited | United Kingdom |
|---|
| 2022-03-14 | Solid Biosciences Securities Corporation | Massachusetts |
|---|
| 2021-03-15 | Solid Biosciences UK Limited | United Kingdom |
|---|
| 2021-03-15 | Solid Biosciences Securities Corporation | Massachusetts |
|---|
| 2020-03-12 | Solid Biosciences UK Limited | United Kingdom |
|---|
| 2020-03-12 | Solid Biosciences Securities Corporation | Massachusetts |
|---|
| 2019-03-13 | Solid Biosciences UK Limited | United Kingdom |
|---|
| 2019-03-13 | Solid Suit, LLC | Massachusetts |
|---|
| 2019-03-13 | Solid Biosciences Securities Corporation | Massachusetts |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
|---|
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
|---|
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
|---|
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
|---|
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
|---|